Victorian Cancer Performance Monitoring Framework (VCPMF)
Phase II Pilot
Phase II of the development of a Victorian cancer performance monitoring framework for evaluating the quality and outcomes of cancer care is well underway and inviting feedback from data users at the health services and integrated cancer services.
Phase I of the project involved an extensive indicator development process and the initial capability testing of a suite of state-wide measures.
The Phase II pilot commenced in July 2016 with the aim to pilot the ‘use’ of cancer performance and outcome information for quality improvement.
Phase II involved collating 2013 data for an initial suite of pilot indicators. Results from 2013 were disseminated in December 2016. This was the first step to developing the systematic reporting, analysis and use of cancer data across Victoria. Additional data for 2014 and 2015 is due early 2017.
If you have personally engaged with the results, or have been formally involved in the analysis of data at an ICS or health service level, we would like your feedback.
The VCPMF is a joint initiative of the Victorian Integrated Cancer Services, and the Victorian Department of Health and Human Services.
Victorian Cancer Performance Monitoring Framework
The VCPMF is a joint undertaking between the Victorian Integrated Cancers Services and the Victorian Department of Health and Human Services.
Phase one of the project developed a basic conceptual schema and operational model, put in place a process to develop indicators and embarked on initial capability testing for a suite of six cancer performance indicators, including: Emergency presentation and new cancer diagnosis; Stage at diagnosis; Reporting Eastern Cooperative Oncology Group performance status; Timeliness of initial treatment after cancer diagnosis; Timeliness of adjuvant chemotherapy (intravenous) for stage III colon cancer; Number of lymph nodes examined during colon cancer surgery
The next step is to transition the initial testing of measures into a pilot program to operationalise state-wide performance monitoring.
This stage will involve the ongoing development of indicators and the systematic collection, reporting, analysis and ‘use’ of cancer performance and outcome information for quality improvement.
The data is intended for use by each of the ICS’ and their clinical networks for internal review and analysis in accordance with their own governance processes. Each ICS will play a central role in reviewing and analysing their respective data to identify aspects of cancer care in need of further analysis and quality improvement.
Monitoring of cancer service performance and clinical outcomes is central to best practice cancer care, efficient service provision and better patient outcomes.